Somera

Target Volume Delineation for Pediatric cancers

Recent developments in radiation and neuro-oncology provide the ability to deliver required radiation dose to target volumes for pediatric brain tumors while avoiding sensitive normal central nervous system (CNS) structures uninvolved by tumor. Many CNS target volumes are smaller than in previous years due to better understanding of areas at risk for recurrence or involvement and patterns of spread for a given diagnoses. Advances in neuroimaging and treatment planning software allow for better delineation of tumors and normal neuroanatomy

Somera

NCCN Guidelines Version 1.2026 Prostate Cancer

Somera

Lattice Radiation Therapy in clinical practice: A systematic review

Lattice Radiation Therapy (LRT) is an innovative radiotherapy (RT) technique that allows to concurrently administering ablative doses inside neoplastic lesions and low doses near the adjacent organs at risks (OARs) (See Fig. 1). LRT can be considered as a type of spatially fractionated radiation therapy (SFRT) and it represents the 3-dimensional (3D) configuration of the 2-dimensional (2D) GRID therapy (See Fig. 2) [1]. The heterogeneous dose distribution of a LRT plans entails the creation of a 3D array inside the planning target volume (PTV), where high-dose (vertices or hotspots) and low-dose areas (periphery

Somera

Curative Treatment of Pediatric Hodgkin Lymphoma With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Consolidation Radiotherapy

While COG and Euronet use three risk groups (low, intermediate, and high), the authors chose to dichotomize groups as most included articles categorized patients as limited or advanced disease. Low- and intermediate-risk (IR) diseases in studies describing three risk groups were analyzed within the limited disease group. Each study had their own criteria for risk stratification. Two sets of bias assessments were conducted, using methodologies used by the Pediatric Normal Tissue Effects in Clinic

Somera

Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas

The consensus was discussed during monthly webbased national meetings, and the algorithms were revised until a consensus was achieved. Results: A total of 26 participants were involved in the development of the algorithms. Two treatment algorithms are proposed, one for the initiation of treatment and one for the discontinuation of treatment.

Somera

Results with radical conformal radiotherapy in prostate cancer

Background: Prostate cancer (PCa) is the most common malignant tumor in men in Mexico. There are two treatments with curative potential, such as radical prostatectomy (RP) for localized disease and radical radiotherapy (R-RT). Control rates are determined by the prognostic factors present. Objective: The objective of this study was to determine the control and survival rate with radical conformal radiotherapy (R-CR) in PCa. Methods: The 8.5-year results of an institutional series are presented using Cox proportional hazards analysis and Kaplan-Meier survival.

Somera

Establishment of Twinning Partnership to Improve Pediatric Radiotherapy Outcomes Globally

Childhood cancer is prevalent throughout the world.1 With modern technologies and therapies, high-income countries (HICs) now report cure rates as high as 80% for children with cancer.2,3 However, low- and middle-income countries (LMICs) struggle with lack of health care resources and infrastructure, resulting in upward of 90% of pediatric oncologic deaths occurring in these countries.2-4 As radiotherapy is a critical component of care for children with malignancies, improving quality and access to pediatric radiotherapy services in LMICs is vital.5 Ethiopia is a low-income country (LIC) in sub-Saharan Africa with a multitude of distinct ethnic groups, languages, and religions

Externo

RADIOTERAPIA EN MÉXICO: UNA NECESIDAD URGENTE Y ESTRATÉGICA

El cáncer es la tercera causa de muerte en México con más de 91,500 fallecimientos anuales. Uno de cada dos pacientes requiere radioterapia como parte de su tratamiento, pero nuestro país cuenta con apenas 2 equipos por millón de habitantes, cuando la recomendación internacional es de 4. Esto coloca a México en desventaja incluso frente a países de ingresos bajos.

Acceder

Somera

Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III

Introduction: Post-treatment surveillance is recommended for NSCLC owing to a high risk of recurrence, but evidence on the optimal surveillance method is lacking. This trial evaluates fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) versus contrast-enhanced CT (ceCT) for surveillance in patients with NSCLC.

Acceder

Somera

Irradiación cráneo-espinal pediátrica. Déficit de crecimiento y aspectos dosimétricos.

Antecedentes: La irradiación cráneo-espinal (ICE) tiene un impacto decisivo en el control de tumores pediátricos con alta probabilidad de diseminación por líquido cefalorraquídeo, pero se asocia a defectos del desarrollo de la columna vertebral en etapa de crecimiento. Objetivo: Analizar las alteraciones de columna posteriores a ICE, y la comparación dosimétrica de las técnicas de radioterapia conformada (RC) y arco volumétrico de intensidad modulada (VMAT).

Acceder

Somera

Emerging Role of Targeted Therapies Combined With Radiotherapy in Inoperable Stages I to III NSCLC: A Review From the IASLC ART Subcommittee.

Precision oncology has transformed the management of NSCLC by tailoring treatment to the specific genetic alterations driving oncogenesis. Targeted therapies, such as tyrosine kinase inhibitors, have been found to dramatically improve survival in patients with advanced-stage NSCLC.

Acceder

Somera

Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors

Summary Background In postmenopausal women with oestrogen receptor-positive early breast cancer, 5 years of adjuvant tamoxifen substantially reduces 15-year recurrence and mortality; aromatase inhibitor treatment (AIT) is even more effective. We assess the effects of further AIT among women recurrence-free after at least 5 years of endocrine therapy

Acceder

Somera

Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review

AstraZeneca. He received travel support from the Radiosurgery Society. He is member of the data safety monitoring board or advisory board for Genentech, ViewRay, AstraZeneca, and Roche. He holds leadership or fiduciary roles in the Radiosurgery Society and ASTRO. Ben J. Slotman is president of the Radiosurgery Society.

Acceder

Somera

Stereotactic Radiation Therapy in Children and Young Adults: Can We Apply Adult Treatment Paradigms?

a Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; b Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio; c Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; d Department of Radiation Oncology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; e Department of Radiation Oncology, Stanford University, Stanford, California; and f Department of Radiation Oncology, University of California San Francisco, San Diego, California

Acceder

Somera

Plasma Epstein-Barr Virus DNA Temporal Clearance Pattern During Induction-Concurrent (Chemo)

Purpose: Plasma Epstein−Barr virus (EBV) DNA is a widely used biomarker for nasopharyngeal carcinoma (NPC). Prior investigations predominantly assessed EBV DNA at a single time point, thus neglecting the differential prognostic implications of the temporal clearance pattern of EBV DNA during induction-concurrent (chemo)radiation therapy (RT).

Acceder

Somera

NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation

Corresponding author: Matthew Poppe, MD; E-mail: matthew. poppe@hci.utah.edu This protocol is registered with ClinicalTrials.gov and may be viewed online at https://clinicaltrials.gov/study/NCT03345420 Author Responsible for Statistical Analysis: Kenneth Boucher, PhD. Disclosures: M.M.P. is an investor in PEEL Therapeutics, Inc., and K.E. B. serves as a consultant for Impedimed. M.M.P. also reports the following roles and associations: Vice Chair, Breast Committee, Alliance; Co-Chair, Breast Locoregional Working Group, Alliance; Member, Executive Committee and Board of Directors, Alliance; Member,

Acceder

Somera

Association of Multi-Kingdom Skin Microbiota With Radiation Dermatitis in Patients

Background: The clinical significance of multi-kingdom skin microbiota in acute radiation dermatitis (ARD) is not well understood. We hypothesized that skin microbiota is associated with ARD in patients with breast cancer (BC) undergoing radiation therapy (RT) after reconstructive surgery

Acceder

Externo

Guía para el manejo del dolor en pequeños procedimientos en pediatría

Guía para el manejo del dolor en pequeños procedimientos en pediatría. Dirigida a profesionales. DIRECCIÓN Y COORDINACIÓN Pilar Hilarión Subdirectora. Instituto Universitario Avedis Donabedian - Universitat Autònoma de Barcelona. Red de investigación en servicios de salud en enfermedades crónicas (REDISSEC) Carola Orrego Subdirectora. Instituto Universitario Avedis Donabedian - Universitat Autònoma de Barcelona. Red de investigación en servicios de salud en enfermedades crónicas (REDISSEC) Área Social de la Fundación Bancaria “la Caixa”.

Acceder

Somera

Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy

The definitive management of many pediatric malignancies requires radiation therapy (RT) to the central nervous system (CNS) that may predispose survivors to neurologic complications. A detailed understanding of radiation dosevolume effects is required to maximize the therapeutic ratio of brain irradiation.

Somera

Neurocognitive Late Effects of Chemotherapy in Children

Treatment protocols for childhood cancer have changed rapidly over the years, maintaining a balance between effective therapy and acceptable toxicity.

Somera

Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy

As cancer survival rates continue to improve, longterm adverse effects of treatment on health and quality of life are increasingly important considerations for clinicians, patients, and familymembers. Neurocognitive deficits (NCD) are well established as a common adverse effect in brain tumor survivors, owing to the tumor itself, but also localized brain irradiation treatment.

Somera

Radiation-Induced Cognitive Decline: Challenges and Solutions

Abstract: Radiation therapy, a common treatment for central nervous system cancers, can negatively impact cognitive function, resulting in radiation-induced cognitive decline (RICD). RICD involves a decline in cognitive abilities such as memory and attention, likely due to damage to brain white matter, inflammation, and oxidative stress

Somera

Radiation-Induced Brain Injury: Age Dependency of Neurocognitive

Simple Summary: Radiation therapy-related brain damage with neurocognitive impairment is a common long-term side effect in cancer survivors and significantly impairs the quality of life. Increasing evidence indicates the increased vulnerability of the developing brain to the neurotoxic effects of ionizing radiation (IR).

Somera

Neurocognitive Decline Following Radiotherapy: Mechanisms and Therapeutic Implications

Abstract: The brain undergoes ionizing radiation (IR) exposure in many clinical situations, particularly during radiotherapy for malignant brain tumors. Cranial radiation therapy is related with the hazard of long-term neurocognitive decline.

Somera

FAST-Forward Boost

FAST-Forward Boost A randomised clinical trial testing a 1-week schedule of curative simultaneous integrated boost radiotherapy against a standard 3-week schedule in patients with early breast cancer.

Somera

Guidelines on Prostate Cancer

EAU - EANM - ESTRO - ESUR - ISUP - SIOG Guidelines on Prostate Cancer

Somera

CONSENSO CANCER MAMA 2025

CONSENSO MEXICANO SOBRE DIAGNÓSTICO Y TRATAMIENTO DEL CÁNCER MAMARIO UNDÉCIMA REVISIÓN, ENERO 2025. RADIOONCOLOGÍA: Dra. Adela Poitevín Chacón Radiooncóloga Médica Sur, Ciudad de México. Dra. Christian Haydeé Flores Balcázar Radiooncóloga Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, SS., Ciudad de México.

Externo

TNM Classification of Malignant Tumours 9th Edition

TNM Classification of Malignant Tumours 9th Edition Edited by: James Brierley, Meredith Giuliani, Brian O'Sullivan, Brian Rous, Elizabeth Van Eycken WILEY

Diseñada para apoyar la formación

Target Volume Delineation for Pediatric cancers

NCCN Guidelines Version 1.2026 Prostate Cancer

Lattice Radiation Therapy in clinical practice: A systematic review

Curative Treatment of Pediatric Hodgkin Lymphoma With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Consolidation Radiotherapy

Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas

Results with radical conformal radiotherapy in prostate cancer

Establishment of Twinning Partnership to Improve Pediatric Radiotherapy Outcomes Globally

RADIOTERAPIA EN MÉXICO: UNA NECESIDAD URGENTE Y ESTRATÉGICA

Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III

Irradiación cráneo-espinal pediátrica. Déficit de crecimiento y aspectos dosimétricos.

Emerging Role of Targeted Therapies Combined With Radiotherapy in Inoperable Stages I to III NSCLC: A Review From the IASLC ART Subcommittee.

Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors

Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review

Stereotactic Radiation Therapy in Children and Young Adults: Can We Apply Adult Treatment Paradigms?

Plasma Epstein-Barr Virus DNA Temporal Clearance Pattern During Induction-Concurrent (Chemo)

NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation

Association of Multi-Kingdom Skin Microbiota With Radiation Dermatitis in Patients

Guía para el manejo del dolor en pequeños procedimientos en pediatría

Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy

Neurocognitive Late Effects of Chemotherapy in Children

Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy

Radiation-Induced Cognitive Decline: Challenges and Solutions

Radiation-Induced Brain Injury: Age Dependency of Neurocognitive